This year, as with most, if not all conventions/conferences post-March, the APLAR 2020 was turned into a virtual encounter. I have not been to APLAR since it was held in…
PEARL Virtual Lay Forum 18 October 2020
The COVID-19 pandemic has compelled the entire global community to sail through uncharted waters. As routines were interrupted, we had to adapt to an entirely
Lupus and PAH case conference – 19 September and 11 November, 2020
Refashioning Forrest Gumpâs seminal aphorism, we often hear our mentors say, âLupus is like a box of chocolates, youâll never know what youâre gonna get.â These famous words couldnât be any truer when we were met with the challenge of managing one of our most baffling patients yet.
Virtual PEARL Forum Aug 16, 2020
The global pandemic brought about by the COVID-19 virus has changed the world and the way we work, rest and play. The social distancing and stay-at-home orders have wreaked havoc on patients needing face-to-face encounters, as well as
Lupus Academy: Virtual Annual Meeting
Ensuring the safety of our learners is important to us therefore, we have decided to host the 9th Annual Meeting of the Lupus Academy online…
Help for Taal 22 January 2020
As soon as the news of the taal eruption broke out, Dra. Navarra organized a team to help out with the preparations to provide the displaced residents of taal whatever they need. Donations in cash and in kind came flowing in.
UST Rheum 2011-2015 case discussion 19 June 2020
Virtual Zoom case discussion with UST Rheumies 2011-2015
Online Learning at the time of COVID19 Pandemic
In mid-March 2020, Rheumatology trainees became suddenly home-bound and community quarantined with UST Hospital in lockdown resulting from the unprecedented COVID19 pandemic. We were to go on duty every 1-2 weeks, schedule patients for online consultation, and don complete personal protective equipment as necessary on physical patient encounters.
HCQ supply amidst Covid pandemic
Introduction: Covid pandemic has led to an acute shortage of hydroxychloroquine (HCQ) for our patients. Here and around the world, concerns of HCQ supply shortages for patients with rheumatic disease are increasing due in part to the interest of the scientific community for HCQ as potential therapy for Covid-19.